AstraZeneca is a posterchild of the UK stock market as Britain's largest listed company. So it's telling that it too is warning that there is a risk a trade war could damage both its bottom line and its drug development Bloomberg's Caroline Hepker and Stephen Carroll spoke to the pharmaceutical giant's CFO Aradhana Sarin as the company posted its first quarter earnings figures.

Senior Fellow at Council on Foreign Relations Rebecca Patterson Talks "Too Much"
07:54

Chief Economist at New Century Advisors Claudia Sahm Talks Labor Market
08:57

NEC Director Kevin Hassett Talks US Debt
09:38